Pediatric ovarian tissue cryopreservation: time to lift the experimental label?
As childhood cancer diagnoses increase and treatments improve survivorship, fertility preservation has emerged as an integral component of the comprehensive cancer treatment plan. The 5-year overall survival rate for childhood cancer has increased from 58% in patients diagnosed between 1975 and 1977 to 83% in those diagnosed between 2002 and 2008 (1). The American Society of Clinical Oncology recognizes fertility preservation as a key survivorship issue and utilizes fertility treatment as a quality care measure.
Source: fertstert.org
Pediatric ovarian tissue cryopreservation: time to lift the experimental label?
Published in Embryology and Reproductive Medicine
More from Embryology and Reproductive MedicineMore posts in Embryology and Reproductive Medicine »
- Life after Stillbirth
- The possible impact of COVID 19 on fertility and ART
- Human embryonic stem cell–derived blastocyst-like spheroids resemble human trophectoderm during early implantation process
- What support is available for you in hospital if you lose your baby
- Estrogen receptor-α immunoreactivity predicts symptom severity and pain recurrence in deep endometriosis
Be First to Comment